David Hong, Sung-Hee Song, Heayoung Shin, Minjung Bak, Juwon Kim, Darae Kim, Ju Youn Kim, Jeong Hoon Yang, Seung-Jung Park, Jin-Oh Choi, Young Keun On, Kyoung-Min Park
{"title":"保留射血分数预测心力衰竭的人工智能心电图模型:一项单中心研究。","authors":"David Hong, Sung-Hee Song, Heayoung Shin, Minjung Bak, Juwon Kim, Darae Kim, Ju Youn Kim, Jeong Hoon Yang, Seung-Jung Park, Jin-Oh Choi, Young Keun On, Kyoung-Min Park","doi":"10.1093/ehjdh/ztaf080","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Heart failure with preserved ejection fraction (HFpEF) is difficult to diagnose due to the lack of a definitive diagnostic marker; multiple tests are required, including advanced evaluations. This study aimed to develop an artificial intelligence (AI)-enabled electrocardiogram (ECG) model for predicting HFpEF.</p><p><strong>Methods and results: </strong>This retrospective cohort study included patients from a single tertiary centre who underwent echocardiography, N-terminal prohormone of B-type natriuretic peptide measurement, and ECG within a defined timeframe. Patients were classified as HFpEF (HFA-PEFF score ≥5) or control (HFA-PEFF score <5). Patients were divided into training, validation, and test subsets at a 7:1:2 ratio for model development and validation. Using the collected ECGs, a convolutional neural network was trained to predict HFpEF; its performance was assessed using the area under the receiver operating characteristic curve (AUROC). Among the 13 081 patients included, 5795 (44.3%) were classified as HFpEF and 7286 (55.7%) were classified as control. The AI-enabled ECG model demonstrated good discriminative performance [AUROC 0.81; 95% confidence interval (CI) 0.79-0.82]. Subgroup analyses stratified by HFpEF risk factors confirmed consistent model performance. Prognostic evaluation revealed that patients with a positive AI-ECG classification experienced significantly worse outcomes relative to those with a negative classification, including higher risks of cardiac death (1.1% vs. 0.1%; hazard ratio 9.56; 95% CI 1.24-73.53; <i>P</i> = 0.030) and heart failure hospitalization (2.8% vs. 0.6%; hazard ratio 5.91; 95% CI 2.08-16.81; <i>P</i> = 0.001) at 5 year.</p><p><strong>Conclusion: </strong>The AI-ECG model is a reliable tool for predicting HFpEF, as defined by the HFA-PEFF score, and effectively stratifies patients according to prognosis. Integration of this model into clinical practice may simplify and enhance the diagnostic process for HFpEF.</p>","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"6 5","pages":"959-968"},"PeriodicalIF":4.4000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12450526/pdf/","citationCount":"0","resultStr":"{\"title\":\"Artificial intelligence-enabled electrocardiogram model for predicting heart failure with preserved ejection fraction: a single-center study.\",\"authors\":\"David Hong, Sung-Hee Song, Heayoung Shin, Minjung Bak, Juwon Kim, Darae Kim, Ju Youn Kim, Jeong Hoon Yang, Seung-Jung Park, Jin-Oh Choi, Young Keun On, Kyoung-Min Park\",\"doi\":\"10.1093/ehjdh/ztaf080\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>Heart failure with preserved ejection fraction (HFpEF) is difficult to diagnose due to the lack of a definitive diagnostic marker; multiple tests are required, including advanced evaluations. This study aimed to develop an artificial intelligence (AI)-enabled electrocardiogram (ECG) model for predicting HFpEF.</p><p><strong>Methods and results: </strong>This retrospective cohort study included patients from a single tertiary centre who underwent echocardiography, N-terminal prohormone of B-type natriuretic peptide measurement, and ECG within a defined timeframe. Patients were classified as HFpEF (HFA-PEFF score ≥5) or control (HFA-PEFF score <5). Patients were divided into training, validation, and test subsets at a 7:1:2 ratio for model development and validation. Using the collected ECGs, a convolutional neural network was trained to predict HFpEF; its performance was assessed using the area under the receiver operating characteristic curve (AUROC). Among the 13 081 patients included, 5795 (44.3%) were classified as HFpEF and 7286 (55.7%) were classified as control. The AI-enabled ECG model demonstrated good discriminative performance [AUROC 0.81; 95% confidence interval (CI) 0.79-0.82]. Subgroup analyses stratified by HFpEF risk factors confirmed consistent model performance. Prognostic evaluation revealed that patients with a positive AI-ECG classification experienced significantly worse outcomes relative to those with a negative classification, including higher risks of cardiac death (1.1% vs. 0.1%; hazard ratio 9.56; 95% CI 1.24-73.53; <i>P</i> = 0.030) and heart failure hospitalization (2.8% vs. 0.6%; hazard ratio 5.91; 95% CI 2.08-16.81; <i>P</i> = 0.001) at 5 year.</p><p><strong>Conclusion: </strong>The AI-ECG model is a reliable tool for predicting HFpEF, as defined by the HFA-PEFF score, and effectively stratifies patients according to prognosis. Integration of this model into clinical practice may simplify and enhance the diagnostic process for HFpEF.</p>\",\"PeriodicalId\":72965,\"journal\":{\"name\":\"European heart journal. Digital health\",\"volume\":\"6 5\",\"pages\":\"959-968\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12450526/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European heart journal. Digital health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/ehjdh/ztaf080\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European heart journal. Digital health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjdh/ztaf080","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
目的:由于缺乏明确的诊断指标,保留射血分数的心力衰竭(HFpEF)难以诊断;需要进行多次测试,包括高级评估。本研究旨在开发一种人工智能(AI)支持的心电图(ECG)模型来预测HFpEF。方法和结果:这项回顾性队列研究包括来自单一三级中心的患者,他们在规定的时间内接受了超声心动图、b型利钠肽n端激素原测量和心电图检查。患者在5年时被分为HFpEF (HFA-PEFF评分≥5)或对照组(HFA-PEFF评分P = 0.030)和心力衰竭住院(2.8% vs. 0.6%;风险比5.91;95% CI 2.08-16.81; P = 0.001)。结论:AI-ECG模型是预测HFA-PEFF评分定义的HFpEF的可靠工具,可根据预后对患者进行有效分层。将该模型整合到临床实践中可以简化和提高HFpEF的诊断过程。
Artificial intelligence-enabled electrocardiogram model for predicting heart failure with preserved ejection fraction: a single-center study.
Aims: Heart failure with preserved ejection fraction (HFpEF) is difficult to diagnose due to the lack of a definitive diagnostic marker; multiple tests are required, including advanced evaluations. This study aimed to develop an artificial intelligence (AI)-enabled electrocardiogram (ECG) model for predicting HFpEF.
Methods and results: This retrospective cohort study included patients from a single tertiary centre who underwent echocardiography, N-terminal prohormone of B-type natriuretic peptide measurement, and ECG within a defined timeframe. Patients were classified as HFpEF (HFA-PEFF score ≥5) or control (HFA-PEFF score <5). Patients were divided into training, validation, and test subsets at a 7:1:2 ratio for model development and validation. Using the collected ECGs, a convolutional neural network was trained to predict HFpEF; its performance was assessed using the area under the receiver operating characteristic curve (AUROC). Among the 13 081 patients included, 5795 (44.3%) were classified as HFpEF and 7286 (55.7%) were classified as control. The AI-enabled ECG model demonstrated good discriminative performance [AUROC 0.81; 95% confidence interval (CI) 0.79-0.82]. Subgroup analyses stratified by HFpEF risk factors confirmed consistent model performance. Prognostic evaluation revealed that patients with a positive AI-ECG classification experienced significantly worse outcomes relative to those with a negative classification, including higher risks of cardiac death (1.1% vs. 0.1%; hazard ratio 9.56; 95% CI 1.24-73.53; P = 0.030) and heart failure hospitalization (2.8% vs. 0.6%; hazard ratio 5.91; 95% CI 2.08-16.81; P = 0.001) at 5 year.
Conclusion: The AI-ECG model is a reliable tool for predicting HFpEF, as defined by the HFA-PEFF score, and effectively stratifies patients according to prognosis. Integration of this model into clinical practice may simplify and enhance the diagnostic process for HFpEF.